Evolve the R&D operating model
Challenge A change in the corporate strategy required the R&D organisation of a MidPharma to evolve and structure its activities from a Life Cycle Management and Product Maintenance focus to a mixed model incorporating NME innovation The R&D head and R&D Leadership team were not clear or aligned on what the new strategic focus, structure, […]
Align and focus market access
Challenge Market changes were causing increased access and pricing pressure, requiring more leadership from the Global Market Access (GMA) team of the diagnostic unit of a Big Pharma The GMA team was not engaging proactively with development and commercial teams to set access and pricing strategy and evolve the company’s development and commercial strategies Solution […]
Enhancing medical affairs capabilities
Challenge Inconsistent development and delivery of publication strategies across the Medical Affairs’ Scientific Communications Leaders (SCLs) responsible for a Big Pharma’s top therapeutic area Many SCLs were not viewed as business partners by development and commercial teams, significantly hindering their ability to deliver effective publication strategies for the portfolio Solution Structured discussions with 16 development, […]
Strengthen and rebalance R&D capabilities
Challenge Following a new corporate strategy, a MidPharma had re-oriented its R&D strategy to improve external innovation sourcing and broaden its technology focus Though the new strategy was clear, the details of the capabilities required to execute it, both existing and new, were less clear, and there was no step-wise plan to rebalance capabilities Solution […]
Increase digital impact
Challenge The digital function of a leading Big Pharma was not creating maximum value for the company because of often poor integration with business teams across the value chain The digital function was seen as a service provider, not a business partner, and needed to drive a digital agenda in the organization through a partnership […]
Improve analytics capabilities
Challenge Market Analytics leaders in a global Big Pharma’s European affiliates were concerned that their preparing of a high number of forecast scenarios was not helping decision making To address this they wanted to assess probabilistic forecasting as an approach to improve decision-making efficiency Solution Created and ran a one-day workshop with Analytics teams from […]
Create insight for R&D partnerships
Challenge A biotech with a specific therapeutic expertise had developed two lead assets that had potential in several non-core indications and sought partnerships to progress its assets Business Development activities had stalled and had not yielded sufficient contact with the senior R&D executives who would be open to creative partnership approaches for the various indications […]
Align and engage medical affairs
Challenge A Big Pharma Medical Affairs team for a leading immunotherapy portfolio was not delivering as effectively as it could across the multiple indications it was covering The organisational structure and operating model did not support the complexity of multi-indication medical information requirements Solution Interviewed all Medical Affairs and related stakeholders to understand the constraints […]
Develop insight and focus to raise funds
Challenge An early stage biotech sought competitive insight and a business development narrative to support fund-raising and the consideration of suitable partnership deals to enable expansion The biotech’s technology was highly innovative with a corresponding recent rapid growth in the number of companies and pipeline products that were either precedents or competitors Solution We carried […]
Create corporate growth strategy
Challenge An early-stage biotech with a highly innovative new technology that had multiple therapeutic area and indication possibilities sought a focus for its further product and technology developments The management team and board did not have an evidence-based view on which opportunities were the best ones to pursue for further corporate growth Solution Analysed and […]